BOLT vs CCI · rev $7.7M vs P/E 40, rev $6.57B
Bolt Biotherapeutics (BOLT) versus Crown Castle (CCI) — a side-by-side from cached financials, not a winner call.
Bolt Biotherapeutics (BOLT) is a biotechnology company listed on US.
Crown Castle (CCI) is a reit - specialty company listed on US.
Latest reported BOLT revenue for 2024-12-31 was $7.7M. Net income was -$63.1M. Revenue was down 2.4% from 2023-12-31 to 2024-12-31. BOLT currently screens at market cap $11.3M.
Latest reported CCI revenue for 2024-12-31 was $6.57B. Net income was -$3.90B. Revenue was down 5.9% from 2023-12-31 to 2024-12-31. CCI currently screens at market cap $40.93B and trailing P/E 39.6.
BOLT currently screens at market cap $11.3M. CCI currently screens at market cap $40.93B and trailing P/E 39.6.
Not investment advice. Open the BOLT and CCI stock pages for the full models.
Not investment advice.